Literature DB >> 19631507

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Alessandro Liberati1, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher.   

Abstract

Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement--a reporting guideline published in 1999--there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realizing these issues, an international group that included experienced authors and methodologists developed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this Explanation and Elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA Statement, this document, and the associated Web site (http://www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.

Mesh:

Year:  2009        PMID: 19631507     DOI: 10.1016/j.jclinepi.2009.06.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2000 in total

Review 1.  Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Catherine L Tacon; John McCaffrey; Anthony Delaney
Journal:  Intensive Care Med       Date:  2011-12-08       Impact factor: 17.440

Review 2.  Efficacy of nonsurgical interventions for anterior knee pain: systematic review and meta-analysis of randomized trials.

Authors:  Natalie J Collins; Leanne M Bisset; Kay M Crossley; Bill Vicenzino
Journal:  Sports Med       Date:  2012-01-01       Impact factor: 11.136

Review 3.  Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation.

Authors:  Eleni Korompoki; Filippos T Filippidis; Peter B Nielsen; Angela Del Giudice; Gregory Y H Lip; Joji B Kuramatsu; Hagen B Huttner; Jiming Fang; Sam Schulman; Joan Martí-Fàbregas; Celine S Gathier; Anand Viswanathan; Alessandro Biffi; Daniela Poli; Christian Weimar; Uwe Malzahn; Peter Heuschmann; Roland Veltkamp
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910

Review 4.  Successful Reperfusion With Intravenous Thrombolysis Preceding Mechanical Thrombectomy in Large-Vessel Occlusions.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Peter D Schellinger; Martin Köhrmann; Panayiotis Varelas; Georgios Magoufis; Maurizio Paciaroni; Valeria Caso; Anne W Alexandrov; Edip Gurol; Andrei V Alexandrov
Journal:  Stroke       Date:  2017-12-06       Impact factor: 7.914

5.  Predicting response to psychiatric surgery: a systematic review of neuroimaging findings.

Authors:  Benjamin Davidson; Hrishikesh Suresh; Maged Goubran; Jennifer S Rabin; Ying Meng; Karim Mithani; Christopher B Pople; Peter Giacobbe; Clement Hamani; Nir Lipsman
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

Review 6.  Circulating miR-21 as a Potential Biomarker for the Diagnosis of Oral Cancer: A Systematic Review with Meta-Analysis.

Authors:  Mario Dioguardi; Giorgia Apollonia Caloro; Luigi Laino; Mario Alovisi; Diego Sovereto; Vito Crincoli; Riccardo Aiuto; Erminia Coccia; Giuseppe Troiano; Lorenzo Lo Muzio
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

7.  Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.

Authors:  Zuen Ren; Shijie Zhou; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  Relation of dietary glycemic load with ischemic and hemorrhagic stroke: a cohort study in Greece and a meta-analysis.

Authors:  Marta Rossi; Federica Turati; Pagona Lagiou; Dimitrios Trichopoulos; Carlo La Vecchia; Antonia Trichopoulou
Journal:  Eur J Nutr       Date:  2014-04-27       Impact factor: 5.614

9.  Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis.

Authors:  Zhaolun Cai; Yiqiong Yin; Yuan Yin; Chaoyong Shen; Jian Wang; Xiaonan Yin; Zhixin Chen; Ye Zhou; Bo Zhang
Journal:  Gastric Cancer       Date:  2018-05-04       Impact factor: 7.370

Review 10.  Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Authors:  Amber Cintosun; Irene Lara-Corrales; Elena Pope
Journal:  Clin Drug Investig       Date:  2020-04       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.